About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,591 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,591 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4981-5000 of 6,591 trials

CompletedRituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to RituximabMonoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.NCT00238238·La Jolla, California and 78 others

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

UnknownEvaluation of Patient and Lesion Specific Prognostic Factors for Standard RadioimmunotherapyMERIT-NHL as an addendum to the International Registry of Radioimmunotherapy (RIT registry) pooling clinical data of patients who suffered from a non-Hodgkin´s lymphoma also…NCT01151358·Homburg (Saar), Saarland and 3 others

Terminated18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in LymphomaThis is a pilot study in adult subjects with aggressive B-cell lymphoma who will receive commercial or research CAR T cell therapy as anticancer treatment.NCT05096234·Stanford, California

RecruitingNovel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHLCD19-CAR-γδT cell therapy is a cellular immunotherapy targeting CD19 to perform CAR modification on allogeneic γδT cells.NCT06838832·Beijing, Beijing Municipality

Active not recruitingStudy of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaThe goal of this clinical study is to learn more about KTE-X19, and how safe and effective it is in adult Japanese participants with relapsed/refractory (r/r) Mantle Cell Lymphoma…NCT06253663·Chiba and 8 others

UnknownA Single-cell Transcriptome Study in Patients With Non-Hodgkin's LymphomaUsing single-cell RNA sequencing, this study will explore the heterogeneity of lymphoma inside and outside the lymph node, identify tumor specific molecular markers and cell…NCT04434833·Shanghai

UnknownTreatment of Relapsed or Refractory Epstein-Barr Virus Positive T-cell Lymphoma With hNeo-TObjective: To evaluate the safety and tolerability of hNeo-T injection in patients with relapsed or refractory EBV-positive T-cell lymphoma.NCT06224049·Shenzhen, Guangdong

WithdrawnInterferon-free Antiviral Treatment of HCV-Positive Genotype 1b Related Indolent Non-Hodgkin LymphomasInterferon-free Antiviral Treatment of HCV-Positive Genotype 1b Related Indolent non-Hodgkin Lymphomas Patients Using Daclatasvir and Asunaprevir: A Pilot StudyNCT02762448

Active not recruitingA Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin LymphomaB-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections).NCT05201248·Beijing, Beijing Municipality and 17 others

CompletedA Phase 2b Study of Baricitinib in Participants With Moderate to Severe PsoriasisThis is a dose-ranging study designed to investigate the efficacy and safety of Baricitinib in the treatment of participants with moderate to severe, chronic plaque psoriasis as…NCT01490632·Bakersfield, California and 34 others

CompletedBone Marrow Transplantation in Treating Patients With Hematologic CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells.NCT00005804·Seattle, Washington

CompletedT Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell GraftsSubjects are being asked to participate in this study because treatment of their disease requires them to receive a stem cell transplant.NCT00368355·Houston, Texas and 1 other

CompletedAssessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)This is a multinational, non-randomized, open-label, Phase 1/2 clinical study to evaluate the safety, tolerability and anti-tumor efficacy of AZD4205 as monotherapy in patients…NCT04105010·New Haven, Connecticut and 49 others

CompletedMinimal Residual Disease in Peripheral T-cell LymphomaAs T-cell receptor sequencing by LymphoTrack is an assay with high sensitivity that can be performed in peripheral blood, the investigators wish to evaluate the ability of this…NCT03297697·Boston, Massachusetts and 2 others

CompletedPeripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerRATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy used to kill tumor cells.NCT00003396·Baltimore, Maryland

RecruitingAcalabrutinib Maintenance for the Treatment of Patients With Large B-cell LymphomaThis phase Ib/II trial studies the side effects and efficacy of maintenance acalabrutinib following cellular therapy in treating patients with large B-cell lymphoma at very high…NCT05256641·Los Angeles, California and 2 others

CompletedMulticenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin LymphomaThis is a multicenter study to assess the anti-tumour activity,to investigate the safety profile and to obtain additional pharmacokinetic information for Aplidin® given as 1-hour…NCT00884286·Lyon and 11 others

UnknownGene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T LymphocytesThe purpose of this study is to evaluate the safety, efficacy and blood kinetics of autologous T cells genetically modified to express anti-CD19 Chimeric Antigen Receptor in…NCT02134262·Shimotsuke, Tochigi

Unknown18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell LymphomaThe purpose of this study is to evaluate whether 18F-FDG PET/CT-based prognostic model of diffuse large B-cell lymphoma can predict disease progressionNCT02928861·Beijing, Beijing Municipality and 1 other

RecruitingZanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein ExpressionThis study aim to evaluate the efficacy and safety of zanubrutinib combined with R-CHOP in the treatment of DLBCL patients with p53 protein expression.NCT06005870·Wuhan, Hubei

PreviousPage 250 of 330Next